Angela Shy, MD
Child & Adolescent Psychiatry · Little Rock, ARNPI 1629199690
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 28.4% of the total. 2025 is the largest year on record at $270, 3.6 times the $76 reported in 2022.
Across 29 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$163
- Lundbeck LLC$119
- Supernus Pharmaceuticals, Inc.$105
- Neurocrine Biosciences, Inc.$62
- Johnson & Johnson$44
- Ironshore Pharmaceuticals Inc.$40
- plus $41 from 2 others
What the payments were for
- Food & beverage$574100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $163 |
| Lundbeck LLC | 6 | $119 |
| Supernus Pharmaceuticals, Inc. | 4 | $105 |
| Neurocrine Biosciences, Inc. | 4 | $62 |
| Johnson & Johnson | 2 | $44 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
How this compares
$574 in reported general payments places this provider in the 70th percentile of 24 child & adolescent psychiatry providers in Arkansas.
See all child & adolescent psychiatry providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 11 | $1,847 |
| Quetiapine Fumarate | 18 | $1,777 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $1,624 |
| Bupropion XlBupropion Hcl | 62 | $1,399 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 30 | $1,235 |
| Lisdexamfetamine Dimesylate | 11 | $1,081 |
| Aripiprazole | 35 | $891 |
| Lamotrigine | 38 | $709 |
| Hydroxyzine Hcl | 41 | $654 |
| Clonazepam | 83 | $645 |
| Trazodone Hcl | 91 | $538 |
| Prazosin Hcl | 29 | $518 |
| Mirtazapine | 38 | $481 |
| Buspirone Hcl | 27 | $455 |
| Propranolol Hcl | 38 | $394 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Little Rock
- Ashley DumasLittle Rock$7K
- Ivan AldeaLittle Rock$5K
- Samuel BaylesLittle Rock$1K
- Brandi YarberryLittle Rock$555
- Nichole BauknightLittle Rock$540
- Steve BrownLittle Rock$495
- Brian KubacakLittle Rock$244
- Holly HunterLittle Rock$166
- Molly LambertsenLittle Rock$135
- Stacy SimpsonLittle Rock$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.